Dr. Assanasen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
7703 Floyd Curl Dr
# MC 7810
San Antonio, TX 78229Phone+1 210-567-7477Fax+1 210-564-7466
Summary
- Chatchawin Assanasen, MD, based in San Antonio, TX, specializes in Pediatric Hematology & Oncology. He completed his residency in Pediatrics and fellowship in Pediatric Hematology/Oncology and holds a BA in Natural Science and an MBA. Dr. Assanasen currently serves as the Chief Medical Officer at The University of Texas Health Science Center at San Antonio and has held multiple leadership roles in both clinical and academic settings. His professional work focuses on conditions such as aplastic anemia and sickle-cell anemia, and he is actively involved in healthcare outcomes research. Dr. Assanasen's publications address topics including genomic profiling and methotrexate toxicity, and he has contributed to research on cultural health practices and healthcare in low-resource settings. He has participated in clinical trials, notably investigating glutamic acid's role in mitigating vincristine-induced nerve damage in pediatric cancer patients.
Education & Training
- The University of Texas at San AntonioMBA, 2019 - 2021
- University of Texas Southwestern Medical CenterFellowship, Pediatric Hematology/Oncology, 2000 - 2003
- U Texas SW Med Sch2000 - 2003
- UF SHANDS-JAX1999 - 2000
- University of Florida College of Medicine JacksonvilleResidency, Pediatrics, 1996 - 1999
- U Florida COM1996 - 1999
- St. George's University School of MedicineClass of 1996
- University of PennsylvaniaB.A., Natural Science, 1990
Certifications & Licensure![](https://directory.doximity.com/assets/icons/icon-help-e9f0b148a1e6d1f037dde9f26f025c36bd7c99fd4fe31fd76792996fa2aa5e66.svg)
- TX State Medical License 2011 - 2025
- FL State Medical License 2000 - 2013
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Best Doctor s in America 2016-2018
- Best Doctors in America 2009-2010, 2013-2015
- Winner of Resident Hypothesis Driven Research Award Texas Pediatric Society, 2014
- Join now to see all
Clinical Trials
- Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients With Cancer Start of enrollment: 2007 May 01
Publications & Presentations
PubMed
- 1 citationsSevere Methotrexate Toxicity Following a Capizzi Cycle in an Obese Adolescent With Acute Lymphoblastic Leukemia and Hepatic Steatosis.Julie M Fischer, Oranooj Lertkovit, Scott C Howard, Chatchawin Assanasen, Archie Bleyer
Journal of Pediatric Hematology/oncology. 2024-01-01 - 3 citationsGenomic profiling of subcutaneous patient-derived xenografts reveals immune constraints on tumor evolution in childhood solid cancer.Funan He, Abhik M Bandyopadhyay, Laura J Klesse, Anna Rogojina, Sang H Chun
Nature Communications. 2023-11-22 - 3 citationsComprehensive characterization of patient-derived xenograft models of pediatric leukemia.Anna Rogojina, Laura J Klesse, Erin Butler, Jiwoong Kim, He Zhang
Iscience. 2023-11-17
Journal Articles
- Prophylactic eculizumab for kidney transplantation in a child with atypical hemolytic uremic syndrome due to complement factor H mutationRanch D, Crowther BR, Arar MY, Assanasen C, Pediatric Transplantation, 1/1/2014
- Burkholderia cepacia Septicemia in a Pediatric Oncology Patient: A Pharmacotherapy ChallengeDurham SH, Lee A, Assanasen C, Ann Pharmacother, 1/1/2012
- Ifosfamide Neurotoxicity in Pediatric Patients: A Multi-Institutional Case Series ReportLee A, Henry DW, Ng JS, Parsons K, Poon BB, Schwartz J, Smith T, Assanasen C, Journal of Hematology Oncology Pharmacy, 1/1/2011
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Challenges in Developing Pediatric Cancer Care in Southern Vietnam. Poster PresentationAssanasen C, CoPresenter: Tomlinson, G, Cancer Therapy & Research Center (CTRC) Annual Symposium, UTHSCSA, San Antonio, TX, 1/1/2014
- Intrathecal Cytarabine as substitution for Intrathecal Methotrexate in the setting of NeurotoxicityLewis S, Thomas PJ, Aune GJ, Assanasen C, Pediatric Blood and Cancer, 1/1/2014
- Acute Kidney Injury in Pediatric Acute Lymphoblastic LeukemiaGuo N, Ranch D, Assanasen C, Pediatric Blood and Cancer, 1/1/2014
- Join now to see all
Lectures
- Advances in the Diagnosis and Management of aHUSChicago, IL - 1/1/2014
- The HUS'esUTHSCSA, San Antonio, TX - 1/1/2014
- Southeast Asian Pediatric Hematology Oncology Program (UTSEAPHO): A Global Health Initiative.UTHSCSA, San Antonio, TX - 1/1/2014
- Join now to see all
Press Mentions
- How Is COVID-19 Taking a Toll on Pediatric Cancer Patients?March 5th, 2021
- University Hospital Pediatric Doctors Treating New Subtype of LeukemiaMarch 1st, 2017
Professional Memberships
- Member
- Member
- American Society of Pediatric Hematology OncologyMember
Other Languages
- Thai
External Links
- South Texas Pediatric Blood and Cancer Centerhttps://www.facebook.com/STPBCC
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: